No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
CURV240517C5000
- 0.50
- +0.10+25.00%
15min DelayClose May 10 16:00 ET
0.50High0.50Low
0.50Open0.40Pre Close10 Volume828 Open Interest5.00Strike Price500.00Turnover0.00%IV-0.36%PremiumMay 17, 2024Expiry Date0.52Intrinsic Value100Multiplier5DDays to Expiry0.00Time Value100Contract SizeAmericanOptions Type--Delta--Gamma11.04Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Intraday
- 5D
- 1D
News
Investors Could Be Concerned With Torrid Holdings' (NYSE:CURV) Returns On Capital
What Torrid Holdings Inc.'s (NYSE:CURV) 27% Share Price Gain Is Not Telling You
Those holding Torrid Holdings Inc. (NYSE:CURV) shares would be relieved that the share price has rebounded 27% in the last thirty days, but it needs to keep going to repair the recent damage it has ca
TORRID ANNOUNCES 2024 CASTING CALL AND TOUR ACROSS AMERICA IN SEARCH OF ITS NEXT BRAND MODEL
Express News | Shares of Companies Within the Broader Consumer Discretionary Sector Are Trading Lower Amid Overall Market Weakness on Rate Cut Uncertainty
Torrid Holdings' Dividend Dilemma: Investor Attraction at Risk Amidst Payment Uncertainty and Debt Constraints
Morgan Stanley Adjusts Torrid Price Target to $5 From $4, Maintains Equal Weight Rating
Morgan Stanley Adjusts Torrid Price Target to $5 From $4, Maintains Equal Weight Rating.
Comments
4/1/2024 🦍’s Watchlist 🚨⚡️🚨⚡️🚨⚡️🚨
$Yield10 Bioscience(YTEN.US$ $Lytus Technologies Holdings(LYT.US$ $Avalo Therapeutics(AVTX.US$ $Gamida Cell(GMDA.US$ $Torrid(CURV.US$ $Qilian International(QLI.US$
📊⚡️📊
$Yield10 Bioscience(YTEN.US$ $Lytus Technologies Holdings(LYT.US$ $Avalo Therapeutics(AVTX.US$ $Gamida Cell(GMDA.US$ $Torrid(CURV.US$ $Qilian International(QLI.US$
📊⚡️📊
3
ColumnsTorrid Holdings Gains More Than 25% After Hours After Plus-Sized Clothier Reports Narrower Q4 Loss
$Torrid(CURV.US$ rose more than 25% after hours Thursday after the plus-sized clothing maker beat analyst estimates for Q4 revenues and overall results.
CURV soared 26% to trade at $6.15 shortly before 4:45 p.m. ET after the company reported a $0.04 loss per share – narrower than the $0.07 analysts had reportedly expected.
The company also recorded $293.5 million of quarterly revenues vs. the $276....
CURV soared 26% to trade at $6.15 shortly before 4:45 p.m. ET after the company reported a $0.04 loss per share – narrower than the $0.07 analysts had reportedly expected.
The company also recorded $293.5 million of quarterly revenues vs. the $276....
2
The declining ROCE and revenue despite increased capital deployment is a concerning trend for Torrid Holdings. While the stock has performed well over the past year, these underlying trends do not bode well for its long-term performance.
Read more